Indeed, the anti-HER2 effects of trastuzumab have been shown to work synergistically with the dimerization blocking abilities of pertuzumab in certain breast tumour types, both in vitro and in the clinical setting64, 65. The gene discussed is ERBB2; the disease is breast neoplasm.